Plandai Biotechnology Inc represents values of innovation, sustainability, and scientific excellence. With a mission to provide natural and effective health solutions, the company focuses on utilizing its proprietary technology to extract beneficial compounds from plants. Plandai Biotechnology Inc believes in promoting human health while minimizing environmental impact through the production of high-quality botanical extracts. By integrating science and nature, Plandai Biotechnology Inc is committed to developing groundbreaking products that contribute to overall well-being. Through continuous research and development, the company aims to revolutionize the healthcare industry and enhance the lives of individuals worldwide.

Plandai Biotechnology Inc is primarily present in the United States, South Africa, and Australia.

Some of the significant milestones achieved by Plandai Biotechnology Inc include the successful implementation of its proprietary Phytofare® Catechin Complex extraction process, which enables the company to produce superior bioavailable products. Furthermore, Plandai Biotechnology Inc has secured partnerships and licensing agreements with leading companies to expand its market presence and distribution network. The company has also made progress in conducting clinical trials to demonstrate the effectiveness and safety of its products. Additionally, Plandai Biotechnology Inc has received recognition for its innovative approach to plant bioactives and its commitment to sustainable farming practices.

Plandai Biotechnology Inc is a company specializing in the research, development, and production of plant-based botanical extracts for the health and wellness industry. Founded in 2012, Plandai Biotechnology has since emerged as a leader in phytochemical research and extraction technology. The company's focus lies in harnessing the medicinal and health benefits of phytochemical compounds derived from specific plants, such as green tea and citrus fruits. With a commitment to sustainable practices and innovative solutions, Plandai Biotechnology is dedicated to bringing novel, science-based products to the market that promote overall well-being.

The main competitors of Plandai Biotechnology Inc in the market include companies like TherapeuticsMD Inc, Celgene Corporation, and GW Pharmaceuticals Plc.

Plandai Biotechnology Inc is primarily active in the biotechnology industry.

Plandai Biotechnology Inc is engaged in the development, licensing, and commercialization of highly bioavailable plant extracts for the nutraceutical and pharmaceutical industries. The company's business model focuses on leveraging its proprietary extraction processes to create sustainable, bioactive ingredients from botanical sources. Plandai Biotechnology's advanced plant extraction technology ensures the maximum retention of active compounds, leading to enhanced therapeutic benefits. By partnering with leading global companies, Plandai Biotechnology aims to expand its product portfolio and penetrate new markets. Through its innovative business model, Plandai Biotechnology Inc strives to revolutionize the nutraceutical and pharmaceutical sectors with its scientifically-backed, high-quality plant extracts.

P/E santykio šiuo metu Plandai Biotechnology apskaičiuoti negalima.

KUV šiuo metu negali būti apskaičiuotas Plandai Biotechnology.

AlleAktien kokybės įvertis Plandai Biotechnology yra 4/10.

Pajamos šiuo metu negali būti apskaičiuotos Plandai Biotechnology.

Pelnas šiuo metu negali būti apskaičiuotas Plandai Biotechnology.

Plandai Biotechnology Inc. is an innovative biotechnology company that focuses on the development of plant extracts and bioactive compounds. The company operates in various business areas, including the production of dietary supplements and cosmetic products, as well as the development of pharmaceutical agents. The core of Plandai Biotechnology Inc.'s business model lies in a deep understanding of the unique properties of plants and their potential to develop innovative products. The company operates agricultural farms in South Africa and the USA to cultivate plants that are rich in bioactive compounds. The main products of Plandai Biotechnology Inc. include plant extracts from Rooibos, green tea, and cannabis. These extracts are used in a variety of products, including dietary supplements, cosmetic skincare products, and pharmaceutical drugs. Dietary supplements and cosmetic products Plandai Biotechnology Inc. offers a wide range of dietary supplements and cosmetic products based on the unique properties of plant extracts. These products are formulated naturally and free from artificial additives and chemicals. They are primarily sold online and through selected retailers. One example of a dietary supplement is Phytofare® Catechin Complex, which contains extracts from green tea. The product is rich in antioxidants and helps support the immune system and improve overall well-being. One example of a cosmetic product is Phytofare® Botanical Face Cleanser, which contains Rooibos extracts and other natural ingredients. This cleanser is gentle on the skin and helps improve skin appearance by reducing inflammation and providing antioxidant benefits. Pharmaceutical products Plandai Biotechnology Inc. is working on developing pharmaceutical products based on plant extracts and bioactive compounds. The company has already achieved success in various areas. For example, a cannabis formulation has been developed that meets specific pharmaceutical standards and has high bioavailability. This formulation can be used in the treatment of chronic pain, epileptic seizures, and other conditions. The company also aims to develop drugs to support the immune system, fight cancer, and treat Alzheimer's disease. Plandai Biotechnology Inc. works closely with universities and research institutions to fully harness the potential of plant biotechnology and create medical innovations. Conclusion Plandai Biotechnology Inc. is a key player in the biotechnology industry, bringing its products to market based on plant extracts and innovative compounds. The company also benefits from the growing demand for natural and healthy products that are highly effective with minimal side effects. With its close collaboration with research institutions and universities, Plandai Biotechnology Inc. has impressive expertise and is well-positioned to continue producing innovative products.

Plandai Biotechnology moka dividendą 0 USD, kuris yra paskirstytas per išmokas per metus.

Dividenda šiuo metu negali būti apskaičiuota Plandai Biotechnology arba įmonė dividendų nemoka.

Plandai Biotechnology ISIN yra US72703D1000.

Plandai Biotechnology WKN yra A1JSDB.

Plandai Biotechnology akcijų simbolis yra PLPL.

Per paskutinius 12 mėnesių Plandai Biotechnology išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams Plandai Biotechnology tikėtina išmokės dividendus, kurie sudarys 0 USD.

Plandai Biotechnology šiuo metu yra dydžio dividendų grąža.

Plandai Biotechnology moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Plandai Biotechnology per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 USD. Tai atitinka 0 % dividendų grąžos procentą.

Plandai Biotechnology priskiriamas sektoriui "Sveikata".

Norėdamas gauti paskutinį Plandai Biotechnology dividendą nuo 2024-11-16, kurio dydis yra 0 USD, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-11-16.

Paskutinės dividendų išmokėjimas įvyko 2024-11-16.

2023 metais Plandai Biotechnology išmokėjo 0 USD dividendų.

Plandai Biotechnology dividendai yra mokami USD.